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Exome sequencing identifies novel and recurrent
mutations in GJA8 and CRYGD associated with
inherited cataract
Donna S Mackay, Thomas M Bennett, Susan M Culican and Alan Shiels*

Abstract
Background: Inherited cataract is a clinically important and genetically heterogeneous cause of visual impairment.
Typically, it presents at an early age with or without other ocular/systemic signs and lacks clear phenotype-genotype
correlation rendering both clinical classification and molecular diagnosis challenging. Here we have utilized trio-based
whole exome sequencing to discover mutations in candidate genes underlying autosomal dominant cataract
segregating in three nuclear families.
Results: In family A, we identified a recurrent heterozygous mutation in exon-2 of the gene encoding γD-crystallin
(CRYGD; c.70C > A, p.Pro24Thr) that co-segregated with ‘coralliform’ lens opacities. Families B and C were found
to harbor different novel variants in exon-2 of the gene coding for gap-junction protein α8 (GJA8; c.20T > C,
p.Leu7Pro and c.293A > C, p.His98Pro). Each novel variant co-segregated with disease and was predicted in silico
to have damaging effects on protein function.
Conclusions: Exome sequencing facilitates concurrent mutation-profiling of the burgeoning list of candidate
genes for inherited cataract, and the results can provide enhanced clinical diagnosis and genetic counseling for
affected families.
Keywords: Cataract, Exome sequencing, CRYGD, GJA8

Background
Hereditary forms of cataract constitute a clinically and
genetically heterogeneous condition affecting the ocular
lens [1-3]. Typically, inherited cataract has an early onset
(<40 years) and most cases are diagnosed at birth (congenital), during infancy, or during childhood accounting
for 10%–25% of all pediatric cataract cases [2]. Congenital and infantile forms of cataract are a clinically important cause of impaired visual development that accounts
for 3%–39% of childhood blindness, worldwide [4]. Despite advances in surgical treatment, pediatric cataract
poses a long-term risk of postoperative complications
including secondary glaucoma, nystagmus, and retinal
detachment [5-9].
Cataract can be inherited, either, as an isolated lens
phenotype—usually with autosomal dominant transmission
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and full penetrance—or as part of a genetic/metabolic
disorder (http://www.omim.org) involving additional ocular
defects (e.g., anterior segment dysgenesis MIM107250) and/
or systemic abnormalities (e.g., galactosemia MIM230400).
Under slit-lamp examination, inherited cataract exhibits considerable inter- and intrafamilial phenotypic variation in location, size, shape, density, progression rate, and even color of
the lens opacities [10]. Currently, genetic studies have identified over 39 genes and loci for inherited cataract, with or
without other ocular signs [1,3]. These include gene coding
for α-, β-, and γ-crystallins (e.g., CRYAA, CRYBB2, CRYGD),
α-connexins (GJA3, GJA8) and other lens membrane or
cytoskeleton proteins (e.g., MIP, BFSP2), several transcription
factors (e.g., HSF4, PITX3), and an expanding group of
functionally divergent genes (e.g., EPHA2, TDRD7, FYCO1).
Since mutations in the same gene can cause morphologically different lens opacities and mutations in different genes can cause similar opacities, there is little
genotype-phenotype correlation for inherited cataract
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rendering both clinical classification and molecular
diagnosis challenging.
Traditionally, linkage analysis in extended pedigrees has
been used to map cataract disease loci to specific chromosome regions and thereby limit the number of positional
candidate genes that need to be conventionally sequenced
in order to discover underlying mutations. However, the
advent of next-generation (massively parallel) sequencing
has facilitated the concurrent screening of multiple candidate genes in nuclear families and cases without a family
history. Here, we have undertaken affected child-parenttrio-based whole-exome next-generation sequencing in
order to identify mutations underlying autosomal dominant cataract in three nuclear families.

Results
Cataract families

We investigated three Caucasian-American pedigrees segregating cataract with autosomal dominant transmission
in the absence of other ocular and/or systemic abnormalities (Figures 1A and 2A,D). A review of ophthalmic
records indicated that bilateral cataract was diagnosed at
birth (congenital) or during infancy in all three families
with age-at-surgery ranging from 3 months to 1 year. In
family A, the lens opacities appeared similar to those first
described by Gunn in 1895 as resembling a piece of coral
or coralliform [11]. No clinical images of lens opacities
were available for family B or C, and none of the families
had a sufficient number of meiotic events (≥10) to support
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independent linkage analysis. Instead, an affected child–
parent plus spouse trio from each family was selected for
whole-exome sequencing.
Candidate genes and exome sequences

We pre-selected 39 candidate genes for inherited cataract
(Additional file 1) cited in the OMIM (http://www.omim.
org), Cat-Map (http://cat-map.wustl.edu/), and iSyTE (http://
bioinformatics.udel.edu/Research/iSyTE) databases [3,12].
The candidate list comprises genes known to be highly
expressed in the lens including those coding for cystallins,
connexins, and other lens membrane/cytoskeletal proteins,
along with several more widely expressed genes that are
associated with cataract and other limited eye/systemic
conditions. Collectively, these candidate genes span over
111,000 bps of the genome and contain 300 exons located
on chromosomes 1–13, 16, 17, 19–22, and X.
For all nine exome samples, over 98% of total paired-end
reads were mapped to the reference genome (Additional
file 2). Approximately 72%–84% of mapped reads were
present in the captured exomes, and the average meanmapped read-depth was 149.2X. With the exception of one
sample in family C (C-I:1), >97% of each exome achieved a
read-depth of ≥10X coverage, yielding a total of >38,900
single nucleotide polymorphisms (SNPs), of which >8,400
were non-synonymous and >1,400 were novel. For exome
C-I:1, 80.61% reached ≥10X coverage yielding a total of
34,435 SNPs (7,639 non-synonymous and 1,331 novel). In
addition, exome C-I:1 contained several more unexpected

Figure 1 Mutation analysis of inherited cataract in family A. (A) Pedigree of family A. Squares denote males, circles denote females, and
filled symbols denote affected status. The trio of individuals I:1, I:2, and II:1 was subject to exome sequencing. (B) Photograph of coralliform lens
opacities in the left eye of individual II:2 just prior to surgery at 3 months of age. (C) Sanger sequence of CRYGD showing the heterozygous c.70
C > A and p.Pro24Thr mutation found in affected individuals I:2, II:1, and II:2 (upper trace) but not in the unaffected spouse I:1 (lower trace).
Horizontal bars indicate the codon reading frame. (D) Amino acid alignment of CRYGD showing low cross-species conservation of Pro24.
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Figure 2 Mutation analysis of inherited cataract in family B and family C. (A) Pedigree of family B. The trio of individuals I:1, I:2, and II:1 was
subject to exome sequencing. (B) Sanger sequence of GJA8 showing the heterozygous c.20 T > C, and p.Leu7Pro mutation found in affected
individuals I:1, II:1, II:2, and II:3 but not in the affected spouse I:2 (lower trace). Horizontal bars indicate the codon reading frame. (C) Amino acid
alignment of GJA8 showing high cross-species conservation of Leu7. (D) Pedigree showing family C. The trio of individuals I:1, I:2, and II:2 was
subject to exome sequencing. (E) Sanger sequence of GJA8 showing the heterozygous c. 293A > C and p.His98Pro mutation found in affected
individuals I:1 and II:2 (upper trace) but not in the unaffected individuals I:2 and II:1 (lower trace). Horizontal bars indicate the codon reading-frame.
(F) Amino acid alignment of GJA8 showing high cross-species conservation of His98.

regions of low coverage (gaps) than those detected in the
other exomes (Additional file 2). However, the reduced
coverage of exome C-I:1 did not compromise analysis of
variants in the candidate genes of interest. Coverage of the
39 candidate genes exceeded a read-depth of >10X with
three exceptions. The iron response element (IRE) of FTL
is located in the 5′-UTR (untranslated region) and was not
covered by capture probes. In addition, coverage of the single exons that code for FOXE3 and MAF was incomplete
as previously reported [13]. We excluded mutations in all
three missing gene regions by Sanger sequencing of an
affected member of each family essentially as described
[13,14]. Collectively, from the nine exomes sequenced, 112
variants were identified in 32 of the 39 candidate genes
(Additional file 3). Of these variants, only five did not have
genome reference sequence (rs) numbers and were potentially novel variants.

Family A variants

A review of the exome SNPs in family A with the list of
candidate genes for cataract identified a total of 76 variants in 28 of 39 genes (Additional file 1 and Additional
file 3). Of these, six variants (two coding/missense and
four non-coding/synonymous) in five candidate genes
were found in both affected relatives and not in the unaffected spouse. However, five of these variants associated
with four candidate genes (SLC16A12, PAX6, CRYAB,
GALK1) were excluded as disease-causing mutations as
they have minor allele frequencies (MAFs) >0.01% (range
8.5%–52.4%) in Caucasians (Additional file 3). We note
that the variant rs3740030 in SLC16A12 on chromosome
10 (chr10:91,222,287) has previously been associated with
age-related cataract [15]. As rs3740030 was first thought
to be a non-coding variant located in the 5′-UTR, the
authors proposed a complex functional mechanism that
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involved modulation of translational efficiency. However,
rs3740030 is now known to be located in exon-3 of
SLC16A12 (c.49T > G) and was predicted to result in
a non-conservative tryptophan-to-glycine substitution at
codon 17 (p.Trp17Gly). While this variant was also predicted in silico to have a damaging effect on protein function (PolyPhen-2 score =0.997), it had a MAF value of 8.5%
in Caucasians, suggesting that it is unlikely to be disease
causing in family A. The remaining variant, rs28931605, occurred in exon-2 of CRYGD (c.70C > A) on chromosome 2
(chr2:208,989,018) and was predicted to result in the nonconservative substitution of proline-to-threonine at codon
24 (p.Pro24Thr) (Table 1). While this variant was predicted
in silico to be tolerated, benign, or neutral with respect to
protein function (Table 2), it has been previously associated
with autosomal dominant cataract in multiple families
(Additional file 4). The p.Pro24Thr variant has also been
documented as p.Pro23Thr based on N-terminal processing of the of the CRYGD protein that removes the initiator
methionine residue. Here, we have adopted the recommended nomenclature in order to avoid confusion and
re-numbering of other mutations in CRYGD associated
with inherited cataract [16]. Sanger sequencing of all four
members of family A (Figure 1A,C) confirmed that the
p.Pro24Thr variant co-segregated with disease providing
further support for its role as a causal mutation.
Family B variants

A review of the exome SNPs in family B with the candidate gene list, revealed a total of 73 variants in 22 of 39
genes (Additional file 1 and Additional file 3). Only 13
of these variants (12 non-coding or synonymous) associated with 7 of the candidate genes were found in both
affected relatives and not in the unaffected spouse. All
12 non-coding or synonymous variants had MAF
values >0.01% (range 0.4%–45.80%) and were effectively
excluded as disease-causing mutations. The remaining
variant was located in exon-2 of GJA8 (c.20T > C) on
chromosome 1 (chr1:147,380,102) and was predicted to
result in the substitution of leucine-to-proline at codon
7 (p.Leu7Pro) (Table 1). The p.Leu7Pro substitution represented a relatively conservative change with the nonpolar, side-chain of leucine ([CH3]2-CH-CH2-) replaced
by the unusual non-polar, side-ring of proline (−CH2CH2-CH2-). However, Leu7 is phylogenetically conserved

in GJA8 (Figure 2C), and the Pro7 substitution was
predicted in silico to have probably damaging effects
on protein function (Table 2). Sanger sequencing of
all five members of family B (Figure 2A,B) confirmed
that the novel p.Leu7Pro variant in GJA8 co-segregated
with cataract further suggesting that it was the diseasecausing mutation.
Family C variants

A review of the exome SNPs in family C using the candidate gene list yielded a total of 82 variants in 23 of the
39 genes (Additional file 1 and Additional file 3). However, only three of these variants associated with the
candidate genes, WFS1, BFSP1, and GJA8, were present
in both affected relatives but not in the unaffected
spouse. The variants associated with WFS1 (rs734312)
and BFSP1 (rs2281207) had MAF values of 54.69% and
25.74%, respectively, and were excluded as causative
mutations. The remaining variant occurred in exon-2 of
GJA8 (c.293A > C) on chromosome 1 (chr1:147,380,375)
and was predicted to result in a non-conservative substitution of histidine-to-proline at codon 98 (p.His98Pro)
(Table 1). Histidine 98 is phylogenetically conserved across
species (Figure 2F), and this variant was also predicted
to have damaging effects on protein function using six
mutation prediction programs (Table 2). Sanger sequencing of all four members of family C (Figure 2D,E)
confirmed that the novel p.His98Pro variant in GJA8
co-segregated with cataract, consistent with it being the
disease-causing mutation.

Discussion
Several recent studies have employed exome sequencing
of index patients or probands in multiple families in
order to discover mutations in candidate genes underlying autosomal dominant and recessive forms of cataract [13,17-19]. In this study, we have used trio-based
exome sequencing to uncover a recurrent missense mutation in CRYGD (p.Pro24Thr) and two novel missense
mutations in GJA8 (p.Leu7Pro, p.His98Pro) associated
with autosomal dominant cataract in three nuclear
families. Child–parent trios offer the initial benefit of
co-segregation testing during exome variant analysis, but
this advantage may be offset in larger cohorts of families
by the additional sequencing costs. The p.Pro24Thr

Table 1 Summary of mutations detected by exome sequencing of trios from families A, B, and C
Pedigree (numbers affected)

Physical location
of variant

Candidate
gene (ID)

Exon

cDNA variant

Protein variant

Allele frequency
(EVS)*

Status

A (3)

chr2:208,989,018

CRYGD (1412)

2

c.70C > A

p.Pro24Thr

0/8,600

Recurrent
(Additional file 5)

B (4)

chr1:147,380,102

GJA8 (2703)

2

c.20T > C

p.Leu7Pro

0/8,600

Novel

C (2)

chr1:147,380,375

GJA8 (2703)

2

c.293A > C

p.His98Pro

0/8,600

Novel

*Allele frequencies for European Americans listed on the Exome Variant Server.
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Table 2 In silico predictions of functional effects for the three mutations identified in this study
Prediction program

SIFT

Polyphen-2

PMUT

PANTHER

PON-P2

MutPred

CRYGD

GJA8

GJA8

c.70C > A

c.20T > C

c.293A > C

p.Pro24Thr

p.Leu7Pro

p.His98Pro

Value (<0.05)

0.10

0.00

0.00

Prediction

Tolerated

Not tolerated

Not tolerated

Score

0.084

0.991

1.000

Prediction

Benign

Probably damaging

Probably damaging

NN output

0.0936

0.8749

0.7822

Reliability

8

7

5

Prediction

Neutral

Pathological

Pathological

subPSEC (<−3)

−2.35974

−4.3388

−3.98807

Pdeleterious (>0.5)

0.34519

0.79148

0.72871

Probability for pathogenicity

0.479

0.947

0.444

Standard error

0.332

0.050

0.090

Prediction

Unknown

Pathogenic

Unknown

Probability of deleterious mutation

0.840

0.918

0.889

Molecular mechanisms disrupted

Loss of stability (p =0.0067)
Gain of disorder (p =0.0099)

substitution in CRYGD has now been identified in some
14 different families, mostly segregating coralliform cataract that affects more than 133 individuals with varied
ethnic backgrounds and constitutes the most recurrent
missense mutation in a crystallin gene to be associated
with inherited cataract (Additional file 4). The novel mutations found in GJA8 increase the mutation spectrum of
this connexin gene to at least 32 different mutations segregating in 38 families making it one of the most common
non-crystallin genes to be associated with inherited
cataract in humans (Additional file 5).
CRYGD (MIM: 123690) consists of three exons and
encodes γD-crystallin—a hydrophylic protein of 174
amino acids that is characterized by two βγ-crystallin
domains each formed by two repeat Greek-key motifs of
approximately 40 residues. CRYGD is expressed at high
concentrations in fiber cells of mammalian lenses and
plays an important structural role in establishing lens
transparency and gradient refractive index [20]. Proline
at position 24 is located within the first Greek-key motif
of human CRYGD but is not well conserved across species (replaced by serine in the mouse and threonine in
the zebrafish). Consequently, in silico analysis predicted
that the Pro24Thr substitution was benign (Table 2).
Further, NMR-spectroscopy and X-ray crystallography
have indicated that the Pro24 and Thr24 proteins are
structurally similar overall [21,22]. However, the Thr24
mutant exhibits local conformational and dynamic differences that may initiate aggregation or polymerization
and in vitro experiments have shown that the Thr24

protein exhibits reduced solubility—a property that is
likely to trigger cataract formation [23-25].
GJA8 (MIM: 600897) comprises two exons with exon2 coding for the entire 433 amino acid residues of gapjunction protein α8 or connexin 50. GJA8 contains four
transmembrane domains that are joined by two extracellular loops and one cytoplasmic loop and flanked by
cytoplasmic N- and C-termini. By forming hexamers, or
hemi-channels, that can dock between adjacent cells to
create gap-junction channels, GJA8 plays an important
role in lens intercellular communication [26]. Of the 32
known coding mutations in GJA8, 30 result in missense
substitutions that, with one exception, are associated with
autosomal dominant cataract, and the remaining two are
frameshift mutations associated with autosomal recessive
cataract (Additional file 5). Most of the missense substitutions are located within the N-terminal half of the protein,
which also contains the conserved connexin domain
(pfam00029; amino acids 3–109). The novel p.Leu7Pro
substitution found in family B is the first to be located at
the cytosolic N-terminal end of human GJA8. Support for
its pathogenicity in humans is provided by the SHR-Dca
rat strain, which inherits semi-dominant cataract [27].
Heterozygous (+/Dca) mutants develop nuclear pulverulent opacities and smaller eyes than wild-type, while
homozygotes (Dca/Dca) present with severe microphthalmia and a hypoplastic lens. The underlying mutation has
been identified as a missense mutation in GJA8 (c.20T > A)
that is predicted to result in a non-conservative
p.Leu7Gln substitution. Both the rat p.Leu7Gln and
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human p.Leu7Pro mutations result in the substitution of a
highly conserved leucine residue with uncharged amino
acids, suggesting that they may exert similar deleterious
effects on GJA8 function.
The novel p.His98Pro mutation identified in family C,
is located near the junction of the second transmembrane domain with the cytoplasmic loop of GJA8. Four
other mutations, p.Val79Leu, p.Pro88Ser, p.Pro88Gln,
and p.Pro88Thr, have previously been localized to the
second transmembrane domain (Additional file 5). Functional expression studies of the relatively conservative
p.Val79Leu substitution results in functional gap-junction
channels with altered voltage-gating and a reduction in
the single-channel open probability [28]. By contrast, neither of the non-conservative p.Pro88Gln and p.Pro88Ser
substitutions was targeted to the plasma membrane, with
the former accumulating in the endoplasmic-reticulum
(ER)-Golgi-complex and the latter forming discrete cytoplasmic inclusions [26]. Based on the non-conservative
nature of the p.His98Pro substitution, we speculate that
this mutant will also fail to reach the plasma membrane
and form functional gap-junction channels

Conclusions
Exome sequencing provides a rational approach to concurrently screen over 39 candidate genes for inherited
cataract in nuclear families or even sporadic cases. In
addition, exome sequencing may enable the discovery of
novel genes underlying inherited cataract and, potentially, genes associated with age-related cataract. However, considerable supporting evidence (e.g., additional
mutations, functional expression in vitro, and/or an animal model) will be required to verify disease causation.
In a clinical setting, results from exome sequencing are
unlikely to be ‘clinically actionable’ with respect to surgical treatment and subsequent management of inherited
cataract. However, such data can contribute to a genecentric clinical classification of inherited cataract and
provide enhanced diagnosis and genetic counseling for
affected families.
Methods
Ethics statement

Ethical approval for this study was obtained from the
Washington University Human Research Protection Office
(HRPO), and written informed consent was provided by all
participants prior to enrollment in accordance with the tenets of the Declaration of Helsinki and Health Insurance
Portability and Accountability Act (HIPAA) regulations.
Family participants

Three Caucasian-American pedigrees segregating autosomal dominant cataract were ascertained through ophthalmic records in the Department of Ophthalmology and
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Visual Sciences at Washington University School of Medicine. Blood samples were obtained from available family
members including a spouse (Figures 1 and 2). Leukocyte
genomic DNA was purified using the Gentra Puregene
Blood kit (Qiagen, Valencia, CA) and quantified by absorbance at 260 nm (NanoDrop 2000, Wilmington, DE).
Exome sequencing

Whole exome capture was achieved using the SureSelect
Human All Exon V5 (50.4 Mb) Kit, according to manufacturer’s instructions (Agilent Technologies). Briefly,
genomic DNA (3 μg) was fragmented (150–200 bp) by
acoustic shearing, ligated to adapter primers, and PCRamplified. Following denaturation (95°C, 5 min), amplified DNA-fragment libraries (~500 ng) were hybridized
in a solution under high stringency (65°C, 24 h) with
biotinylated RNA capture probes (~120 bp). Resulting
DNA/RNA hybrids were recovered by streptavidin-coated
magnetic bead separation (Dynal, Invitrogen, Carlsbad,
CA). Captured DNA was eluted (NaOH) and then subject
to solid phase (flow-cell) next-generation (massively parallel) sequencing on a HiSeq2000 System (Illumina, San
Diego, CA) using the Illumina Multiplexing Sample Preparation Oligo-nucleotide Kit and the HiSeq 2000 Paired-End
Cluster Generation Kit according to the manufacturer’s instructions. Briefly, hybrid-capture libraries were amplified
to add indexing (identifying) tags and sequencing primers
then subjected to paired-end (2 × 101 bp read length),
multiplex sequencing-by-synthesis using fluorescent, cyclic
reversible (3′-blocked) terminators. A pool of three exome
samples (representing a family trio) was sequenced in a
single lane of the sequencer’s flow-cell.
Exome variant analysis

Raw sequence data was aligned to the human reference
genome (build hg19) by NovoalignMPI (www.novocraft.
com), and sequence variants called using the Sequence
Alignment/Map format (SAMtools) and Picard programs
(http://samtools.sourceforge.net/) and further annotated
using SeattleSeq (http://snp.gs.washington.edu/SeattleSeq
Annotation138/). Target coverage and read-depth were
reviewed by the Integrated Genomics Viewer (IGV; http://
www.broadinstitute.org/igv/). Variants were filtered using
the Ingenuity variant analysis website (IVA http://ingenuity.
com) or the gNOME project pipeline (http://gnome.tchlab.
org/) [29]. Identified variants in the pre-selected candidate
genes (Additional file 1) were then reviewed for presence/
absence and frequency in various websites including dbSNP
(http://www.ncbi.nlm.nih.gov/snp/), 1000 genomes (http://
www.1000genomes.org/), and the Exome Variant Server
database (http://evs.gs.washington.edu/EVS/). The predicted
effect on protein function was analyzed using the SIFT
(http://sift.jcvi.org), PolyPhen-2 (http://genetics.bwh.harvard.
edu/pph2/), PMUT (http://mmb2.pcb.ub.es:8080/PMut/),
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PON-P2 (http://structure.bmc.lu.se/PON-P2/), PANTHER
(http://www.pantherdb.org/tools/csnpScoreForm.jsp), and
MutPred (http://mutpred.mutdb.org/) in silico mutation
prediction programs [30-34].

Page 7 of 8

(Core Grant for Vision Research) and by an unrestricted grant to the
Department of Ophthalmology and Visual Sciences from Research to Prevent
Blindness (RPB).
Received: 27 August 2014 Accepted: 23 October 2014

Sanger sequencing

Genomic DNA (2.5 ng/μl, 10 μl reactions) was amplified
(35 cycles) in a GeneAmp 9700 thermal cycler using Top
Taq mastermix kit (Qiagen) and 20 pmol of gene-specific
primers (Additional file 6). Resulting PCR amplicons were
enzyme-purified with ExoSAP-IT (USB Corporation,
Cleveland, OH). The purified amplicons were direct cyclesequenced in both directions with BigDye Terminator
Ready Reaction Mix (v3.1)(Applied Biosystems, Grand
Island, NY) containing M13 forward or reverse sequencing
primers, then ethanol precipitated and detected by capillary
electrophoresis on a 3130xl Genetic Analyzer running
Sequence Analysis (v.6.0) software (Applied Biosystems)
and Chromas (v2.23) software (Technelysium, Tewantin,
Queensland, Australia).

Additional files
Additional file 1: Table S1. Candidate genes for inherited cataract
evaluated in this study.
Additional file 2: Table S2. Sample metrics for exome sequencing of
trios from families A, B, and C.
Additional file 3: Table S3. Exome sequencing variants found in
candidate genes for inherited cataract (Additional file 1, Table S1) in
family trios A, B, and C.
Additional file 4: Table S4. Recurrence of the p.Pro24Thr mutation in
CRYGD associated with autosomal dominant cataract.
Additional file 5: Table S5. Mutation profile of GJA8.
Additional file 6: Table S6. PCR primers used for Sanger sequencing of
mutations found in CRYGD and GJA8. Each primer used was tailed with
M13 sequences to aid in Sanger sequencing. The forward primers were
tagged with ‘tgtaaaacgacggccagt’ and the reverse primers with
‘caggaaacagctatgacc’.
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OMIM: Online Mendelian Inheritance in Man; MAF: Minor allele frequency;
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